Omeros (OMER) Work In Process (2015 - 2021)

Omeros (OMER) reported Work In Process of $65000.0 for Q3 2021, down 91.84% on a YoY basis from $797000.0 in Q3 2020, and down 71.74% sequentially from $230000.0 in Q2 2021.

Omeros (OMER) Work In Process (2015 - 2021) Analysis & Trends

Omeros (OMER) has 5 years of Work In Process data on file, last reported at $65000.0 in Q3 2021.

  • For the quarter ending Q3 2021, Work In Process fell 91.84% year-over-year to $65000.0; the trailing twelve-month figure through Sep 2021 stood at $65000.0 (down 91.84% YoY), and the FY2020 full-year result was $462000.0, up 36.69% from the prior year.
  • Work In Process eased to $65000.0 in Q3 2021, from $230000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.2 million in Q2 2020 to a low of $65000.0 in Q3 2021.
  • A 3-year average of $474090.9 and a median of $394000.0 in 2020 frame the typical range for Work In Process.
  • Across the five-year window, Work In Process surged 114.16% in 2020 and tumbled 91.84% in 2021, its largest moves.
  • Tracing OMER's Work In Process over 3 years: stood at $338000.0 in 2019, then surged by 36.69% to $462000.0 in 2020, then plunged by 85.93% to $65000.0 in 2021.
  • Business Quant data shows OMER's Work In Process at $65000.0 in Q3 2021, $230000.0 in Q2 2021, and $405000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Omeros 739.31 Mn 739.31 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 65,000.00
Jun 30, 2021 230,000.00
Mar 31, 2021 405,000.00
Dec 31, 2020 462,000.00
Sep 30, 2020 797,000.00
Jun 30, 2020 1.20 Mn
Mar 31, 2020 394,000.00
Dec 31, 2019 338,000.00
Sep 30, 2019 379,000.00
Jun 30, 2019 558,000.00
Mar 31, 2019 392,000.00
Dec 31, 2016 854,000.00
Dec 31, 2015 158,000.00